The prognostic significance of LTBP2 for malignant tumors

Abstract. Background & aims:. At present, increasing reports have shown that latent transforming growth factor-β-binding protein 2 (LTBP2) was associated with the prognosis of many types of cancer. We performed rounded analysis to comprehensively analyze and evaluate the prognostic significance...

Full description

Bibliographic Details
Main Authors: Jianmeng Zhao, MD, Xiaokang Liu, MD, Ke Cong, MD, Jinzhe Chang, MD, Hongqing Shan, MD, Yuenan Zheng, MD, Mihai Dorin Vartolomei.
Format: Article
Language:English
Published: Wolters Kluwer 2022-04-01
Series:Medicine
Online Access:http://journals.lww.com/10.1097/MD.0000000000029207
_version_ 1818205943087759360
author Jianmeng Zhao, MD
Xiaokang Liu, MD
Ke Cong, MD
Jinzhe Chang, MD
Hongqing Shan, MD
Yuenan Zheng, MD
Mihai Dorin Vartolomei.
author_facet Jianmeng Zhao, MD
Xiaokang Liu, MD
Ke Cong, MD
Jinzhe Chang, MD
Hongqing Shan, MD
Yuenan Zheng, MD
Mihai Dorin Vartolomei.
author_sort Jianmeng Zhao, MD
collection DOAJ
description Abstract. Background & aims:. At present, increasing reports have shown that latent transforming growth factor-β-binding protein 2 (LTBP2) was associated with the prognosis of many types of cancer. We performed rounded analysis to comprehensively analyze and evaluate the prognostic significance of LTBP2 for patients with malignant tumors. Methods:. We identified relevant studies by searching database including PubMed, Embase, Cochrane Library, and Web of Science. The odds ratio with its 95% confidence interval (CI) was used to assess the correlation between LTBP2 and clinicopathologic features or overall survival of patients with cancer. Hazard ratio with its 95% CI was used to explore the prognostic risk factors. The analysis was performed and assessed using Review Manager 5.2. Results:. A total of 11 studies including 2322 participants were included in this systematic review. Pooled results showed that malignant tissues experienced higher incidence of high LTBP2 expression when compared with adjacent or normal tissues. Patients with high LTBP2 expression experienced significantly lower 1-year, 2-year, 3-year, and 4-year overall survival rate, with the pooled odds ratios being 0.26 (95% CI 0.13–0.53; P = .0002), 0.27 (95% CI 0.14–0.50; P < .0001), 0.26 (95% CI 0.13–0.53; P = .0002), and 0.21 (95% CI 0.06–0.73; P = .01) respectively. Univariate analysis showed high LTBP2 expression, tumor node metastasis stage, T stage, and N stage were prognostic factors of patients with tumors. Multivariate analysis indicated high LTBP2 expression was an independent prognostic factor. Conclusions:. The present analysis suggested that LTBP2 may have significant association with survival of patients with cancer. High LTBP2 expression was an independent prognostic factor and indicated poor survival.
first_indexed 2024-12-12T04:05:09Z
format Article
id doaj.art-c07cd19072824a8aaae887c9acc8704d
institution Directory Open Access Journal
issn 0025-7974
1536-5964
language English
last_indexed 2024-12-12T04:05:09Z
publishDate 2022-04-01
publisher Wolters Kluwer
record_format Article
series Medicine
spelling doaj.art-c07cd19072824a8aaae887c9acc8704d2022-12-22T00:38:48ZengWolters KluwerMedicine0025-79741536-59642022-04-0110117e2920710.1097/MD.0000000000029207202204290-00008The prognostic significance of LTBP2 for malignant tumorsJianmeng Zhao, MDXiaokang Liu, MDKe Cong, MDJinzhe Chang, MDHongqing Shan, MDYuenan Zheng, MDMihai Dorin Vartolomei.Abstract. Background & aims:. At present, increasing reports have shown that latent transforming growth factor-β-binding protein 2 (LTBP2) was associated with the prognosis of many types of cancer. We performed rounded analysis to comprehensively analyze and evaluate the prognostic significance of LTBP2 for patients with malignant tumors. Methods:. We identified relevant studies by searching database including PubMed, Embase, Cochrane Library, and Web of Science. The odds ratio with its 95% confidence interval (CI) was used to assess the correlation between LTBP2 and clinicopathologic features or overall survival of patients with cancer. Hazard ratio with its 95% CI was used to explore the prognostic risk factors. The analysis was performed and assessed using Review Manager 5.2. Results:. A total of 11 studies including 2322 participants were included in this systematic review. Pooled results showed that malignant tissues experienced higher incidence of high LTBP2 expression when compared with adjacent or normal tissues. Patients with high LTBP2 expression experienced significantly lower 1-year, 2-year, 3-year, and 4-year overall survival rate, with the pooled odds ratios being 0.26 (95% CI 0.13–0.53; P = .0002), 0.27 (95% CI 0.14–0.50; P < .0001), 0.26 (95% CI 0.13–0.53; P = .0002), and 0.21 (95% CI 0.06–0.73; P = .01) respectively. Univariate analysis showed high LTBP2 expression, tumor node metastasis stage, T stage, and N stage were prognostic factors of patients with tumors. Multivariate analysis indicated high LTBP2 expression was an independent prognostic factor. Conclusions:. The present analysis suggested that LTBP2 may have significant association with survival of patients with cancer. High LTBP2 expression was an independent prognostic factor and indicated poor survival.http://journals.lww.com/10.1097/MD.0000000000029207
spellingShingle Jianmeng Zhao, MD
Xiaokang Liu, MD
Ke Cong, MD
Jinzhe Chang, MD
Hongqing Shan, MD
Yuenan Zheng, MD
Mihai Dorin Vartolomei.
The prognostic significance of LTBP2 for malignant tumors
Medicine
title The prognostic significance of LTBP2 for malignant tumors
title_full The prognostic significance of LTBP2 for malignant tumors
title_fullStr The prognostic significance of LTBP2 for malignant tumors
title_full_unstemmed The prognostic significance of LTBP2 for malignant tumors
title_short The prognostic significance of LTBP2 for malignant tumors
title_sort prognostic significance of ltbp2 for malignant tumors
url http://journals.lww.com/10.1097/MD.0000000000029207
work_keys_str_mv AT jianmengzhaomd theprognosticsignificanceofltbp2formalignanttumors
AT xiaokangliumd theprognosticsignificanceofltbp2formalignanttumors
AT kecongmd theprognosticsignificanceofltbp2formalignanttumors
AT jinzhechangmd theprognosticsignificanceofltbp2formalignanttumors
AT hongqingshanmd theprognosticsignificanceofltbp2formalignanttumors
AT yuenanzhengmd theprognosticsignificanceofltbp2formalignanttumors
AT mihaidorinvartolomei theprognosticsignificanceofltbp2formalignanttumors
AT jianmengzhaomd prognosticsignificanceofltbp2formalignanttumors
AT xiaokangliumd prognosticsignificanceofltbp2formalignanttumors
AT kecongmd prognosticsignificanceofltbp2formalignanttumors
AT jinzhechangmd prognosticsignificanceofltbp2formalignanttumors
AT hongqingshanmd prognosticsignificanceofltbp2formalignanttumors
AT yuenanzhengmd prognosticsignificanceofltbp2formalignanttumors
AT mihaidorinvartolomei prognosticsignificanceofltbp2formalignanttumors